Johns Hopkins University’s Collaboration with Pfizer’s Centers for Therapeutic Innovation (CTI)

Johns Hopkins University has been invited to join the group of over 25 institutions who are collaborating with Pfizer’s Centers for Therapeutic Innovation (CTI) network, which is designed to help bridge the gap between early scientific discovery and its translation into new medicines through public-private resource sharing. Pfizer’s CTI program pairs leading researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. Partners in the CTI network include 25 academic institutions, four patient foundations, the NIH and now Johns Hopkins University.

The goal of this new collaboration is to identify large and small molecule compounds with activity in a pathway or target of interest to a JHU researcher and to Pfizer. Together, the collaborators will work to move these compounds into the clinic. Funding amounts range between $100,000 and $250,000 per year, with an approximate 4x invested internally at Pfizer. There will be two informational seminars about this new program on: 

  • June 27 at 2 p.m. in the John G. Rangos, Sr. Building, room 490
  • July 25 at 2 p.m. in the John G. Rangos, Sr. Building, room 490

The seminar will involve an overview presentation by Pfizer (2-3 p.m.) followed by informal discussions with light refreshments provided by Forest City (3-5 p.m.).

See the flyer for more information: Pfizer's CTI